Quincy Medical Group Announces Availability of Innovative, In-Office Treatment for Chronic Nasal Airway Obstruction

QUIN­CY, IL – 3/3/22 – Quin­cy Med­ical Group (QMG) is pleased to announce the avail­abil­i­ty of VivAer®, a min­i­mal­ly-inva­sive FDA-cleared tech­nol­o­gy that pro­vides last­ing relief from chron­ic nasal air­way obstruction.

QMG Ear, Nose, and Throat (ENT) physi­cians Dr. Paul Con­rad and Dr. Abra­ham Sheffield offer this new treat­ment option for patients. Nasal air­way obstruc­tion is one of the most com­mon but often undi­ag­nosed con­di­tions; more than 20 mil­lion Amer­i­cans suf­fer from nasal obstruc­tion in the Unit­ed States.

Nasal obstruc­tion is often caused by anatom­i­cal block­age in the nose, hin­der­ing air­flow. As a result, patients may feel con­gest­ed or ​“stuffy.” Com­mon symp­toms include nasal con­ges­tion or stuffi­ness, trou­ble breath­ing through the nose, trou­ble sleep­ing, and dif­fi­cul­ty breath­ing well dur­ing exer­cise or exer­tion. For many patients, man­age­ment of this con­di­tion with med­ica­tions and sprays is inad­e­quate or offers only tem­po­rary relief.

“If you reg­u­lar­ly expe­ri­ence dif­fi­cul­ty breath­ing through your nose, espe­cial­ly at night, and noth­ing seems to help but decon­ges­tants or Breathe Rights, you like­ly have enlarged nasal turbinates and/​or nasal valve col­lapse,” said Dr. Con­rad. ​“Until recent­ly, find­ing a long-term solu­tion for these prob­lems often meant surgery. Now, with VivAer, we’re able to offer an in-office con­ve­nient, min­i­mal­ly-inva­sive pro­ce­dure that grad­u­al­ly opens your nasal air­way to help you breathe better.”

VivAer fea­tures a thin, wand-like, tem­per­a­ture-con­trolled sty­lus that attach­es to a con­sole. The sty­lus is insert­ed via the nos­tril to gen­tly remod­el the nasal tis­sue and improve air flow using patent­ed tem­per­a­ture-con­trolled radiofre­quen­cy tech­nol­o­gy that deliv­ers pre­cise ther­a­peu­tic ben­e­fits. Treat­ment with VivAer can be per­formed with a local anes­thet­ic dur­ing a rou­tine office vis­it, with no inci­sions, min­i­mal to no down­time, and min­i­mal dis­com­fort. Patients typ­i­cal­ly return to nor­mal activ­i­ty on the same day.

“Chron­ic nasal obstruc­tion can great­ly affect a person’s qual­i­ty of life,” said Dr. Sheffield. ​“Find­ing the most appro­pri­ate treat­ment for each indi­vid­ual is our top pri­or­i­ty. We are excit­ed to offer patients this new treat­ment option.”

For more infor­ma­tion or to sched­ule a con­sul­ta­tion, call (217) 222‑6550, ext. 6900 or vis­it quin​cymed​group​.com/​v​ivaer.